Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025)
Maze Therapeutics' (MAZE) quarterly Treasury Shares came in at $10372.0 in Q4 2025, little changed year-on-year from $10372.0 in Q4 2024, and down 98.26% quarter-over-quarter from $594825.0 in Q3 2025.
Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025) Analysis & Trends
Maze Therapeutics has disclosed Treasury Shares across 2 years of filings, most recently posting $10372.0 for Q4 2025.
- Treasury Shares for Q4 2025 came in at $10372.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $10372.0 (changed 0.0% YoY), and the FY2025 annual result was $10372.0, changed 0.0% from the prior year.
- Treasury Shares came in at $10372.0 for Q4 2025 at Maze Therapeutics, down from $594825.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $594825.0 in Q3 2025 to a low of $10372.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Maze Therapeutics | 1.31 Bn | 1.31 Bn | 18.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,372.00 |
| Dec 31, 2025 | 10,372.00 |
| Sep 30, 2025 | 594,825.00 |
| Sep 30, 2025 | 594,825.00 |
| Dec 31, 2024 | 10,372.00 |
| Dec 31, 2024 | 10,372.00 |
| Sep 30, 2024 | 12,965.00 |
| Sep 30, 2024 | 12,965.00 |